Sangamo Therapeutics
SGMO
#10391
Rank
A$43.72 M
Marketcap
A$0.11
Share price
0.00%
Change (1 day)
-85.94%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are A$32.87 Million. In 2024 the company made an earning of -A$0.15 Billion, an increase over its 2023 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion21.21%
2024 -A$0.15 Billion-17.27%
2023 -A$0.17 Billion-40.88%
2022 -A$0.29 Billion9.79%
2021 -A$0.27 Billion41.52%
2020 -A$0.19 Billion23.17%
2019 -A$0.15 Billion36.33%
2018 -A$0.12 Billion36.89%
2017 -A$80.38 Million-22.32%
2016 -A$0.11 Billion54.86%
2015 -A$66.83 Million75.62%
2014 -A$38.05 Million0.13%
2013 -A$38 Million
2011 -A$51.09 Million43.66%
2010 -A$35.56 Million28.52%
2009 -A$27.67 Million-23.55%
2008 -A$36.2 Million2.45%
2007 -A$35.33 Million19.5%
2006 -A$29.57 Million50.78%
2005 -A$19.61 Million75%
2004 -A$11.21 Million-33.25%
2003 -A$16.79 Million-62.27%
2002 -A$44.49 Million102.82%
2001 -A$21.94 Million23.21%
2000 -A$17.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.04 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.95 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.31 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-A$3.61 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.97 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.75 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.24 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.54 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA